Financial Risk Assessment Of Shanghai Pharmaceutical Co,Ltd.

The pharmaceutical manufacturing is an industry that is always developing and growing.It not only concerns the national economy and people's livelihood,but also shoulders important social responsibilities.With the economic development,the increased disposable income of residents has driven the demand for pharmaceutical products,making the pharmaceutical manufacturing industry more rapid.However,at the same time as rapid development,the financial risks faced by the pharmaceutical manufacturing industry are also more complex and changeable.Financial risks exist objectively in the course of various business activities of the company.For companies that are seriously affected by financial risks at any point,they may cause the company to suffer serious financial crisis and even face the risk of bankruptcy.How to timely assess financial risks for the company becomes more important to say.The article evaluates the financial risk status of Shanghai Pharmaceutical Group with the following points: Firstly,it provides a reasonable financial risk assessment model for Shanghai Pharmaceutical Group.The company's management can use this model to keep abreast of the company's financial status and prevent financial affairs.Crisis,timely financial processing.Secondly,it helps the Shanghai Pharmaceutical Group's management to adjust the company's business strategy rationally.With the help of the financial risk assessment results,the Shanghai Pharmaceutical Group's management can detect the abnormality of the financial status in a timely manner and analyze the causes of the abnormal financial conditions.Adjust the company's business strategy to improve the financial situation.Thirdly,it provides certain reference for decision-making of stakeholders of Shanghai Pharmaceutical Group,establishes a financial risk assessment model suitable for the characteristics of Shanghai Pharmaceutical Group,and can provide more predictions for shareholders,creditors,suppliers and other stakeholders of the company.Sexual information that can truly reflect the status of the company provides a certain reference for the decision-making of these stakeholders.This article takes Shanghai Pharmaceutical Group Co.,Ltd.(hereinafter referredto as Shanghai Pharmaceutical Group)as an example and analyzes the nature and characteristics of its industry,production and operation conditions,financial data and other information,and uses the analytic hierarchy process and efficacy coefficient method to construct the Shanghai Pharmaceutical Group's financial risk.Evaluation model;based on the financial data of Shanghai Pharmaceutical Group from 2014 to2016,based on the constructed financial risk assessment model,the financial status of Shanghai Pharmaceutical Group was evaluated and analyzed,and several points were given based on the results of financial risk assessment.Preventive advice.The dissertation consists of six parts: The first part is the introduction.This part firstly introduces the background and significance of the dissertation research,and then summarizes the research results related to financial risk at home and abroad in recent years,and summarizes the results of theoretical research and literature.And the review provides the theoretical reference and method guidance for the writing of the dissertation.The second part is the related theory of financial risk assessment.This part first introduces the basic content of the paper's research object financial risk definition and characteristics,and then elaborates the thesis.The theoretical methods used in the writing process—Analytic Hierarchy Process(AHP)and Efficiency Coefficients Law(APA)provide theoretical basis and methodological support for the study of the financial risk assessment of Shanghai Pharmaceutical Group.The third part is the construction of the Shanghai Financial Group's financial risk assessment model.The content is the basis for the study of the company's financial risk status.The risk assessment model is constructed through the AHP method and the efficacy coefficient method,which provides technical support for the Shanghai Pharmaceutical Group's financial risk assessment.The fourth part is the financial of the Shanghai Pharmaceutical Group.Analysis of risk assessment results,based on the former The theory,methods and techniques for financial risk assessment are laid out.The financial risk of Shanghai Pharmaceutical Group is calculated and analyzed.Finally,the financial risk assessment results of Shanghai Pharmaceutical Group are obtained.The fifth part is the prevention of financial risks of Shanghai Pharmaceutical Group.Based on the results of the Shanghai Pharmaceutical Group's financial riskassessment,the proposal provides a few precautionary suggestions for the Shanghai Pharmaceutical Group from the perspective of the pharmaceutical industry;the sixth part is the conclusion,combining the previous analysis of the Shanghai Pharmaceutical Group's financial risk status.The financial risk of the company's profitability is high,and the financial risks of debt repayment ability,operational ability,and growth ability are low,and some prospects for the future research of Shanghai Pharmaceutical Group are put forward.Based on the analysis of the actual operating conditions of Shanghai Pharmaceutical Group,the paper establishes a financial risk assessment model using the analytic hierarchy process and efficacy coefficient method,which is conducive to Shanghai Pharmaceutical Group's detection and timely prevention of the company's financial risks,and guarantees the sustainable and stable development of the company.Escort;the financial risk assessment model constructed by the thesis has a certain universality;other companies in the pharmaceutical industry can refer to the Shanghai Financial Group's financial risk assessment model and apply the model to the company's self-examination of financial risks.Can understand the financial status of the company more intuitively and make quick decisions.